Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26,767 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[High sustained virological response to optimized therapy for refractory chronic hepatitis C treatment-na(i)ve patients: a multicenter randomized study].
Chen X, Shang J, Yang R, Xie Q, Gao Z, Xu X, Dou X, Gong G, Chen G, Li J, Chen H, Zhang D, Feng Y, Niu J, Hou J, You H, Wu Y, Zhao P, Rao H, Wei L. Chen X, et al. Among authors: feng y. Zhonghua Gan Zang Bing Za Zhi. 2015 Jun;23(6):412-7. doi: 10.3760/cma.j.issn.1007-3418.2015.06.004. Zhonghua Gan Zang Bing Za Zhi. 2015. PMID: 26236925 Clinical Trial. Chinese.
[The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients].
Rao H, Yang R, Shang J, Xu X, Chen X, Dou X, Feng Y, Gao Z, Xie Q, Li J, You H, Chen G, Niu J, Gong G, Hou J, Chen H, Zhang D, Wei L. Rao H, et al. Among authors: feng y. Zhonghua Nei Ke Za Zhi. 2015 Aug;54(8):699-704. Zhonghua Nei Ke Za Zhi. 2015. PMID: 26674626 Clinical Trial. Chinese.
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study.
Wang J, Zhang Q, Ai J, Liu D, Liu C, Xiang H, Gu Y, Guo Y, Lv J, Huang Y, Liu Y, Xu D, Chen S, Li J, Li Q, Liang J, Bian L, Zhang Z, Guo X, Feng Y, Liu L, Zhang X, Zhang Y, Xie F, Jiang S, Qin W, Wang X, Rao W, Zhang Q, Tian Q, Zhu Y, Cong Q, Xu J, Hou Z, Zhang N, Zhang A, Zu H, Wang Y, Yan Z, Du X, Hou A, Yan Y, Qiu Y, Wu H, Hu S, Deng Y, Ji J, Yang J, Huang J, Zhao Z, Zou S, Ji H, Ge G, Zhong L, He S, Yan X, Yangzhen BB, Qu C, Zhang L, Yang S, Gao X, Lv M, Zhu Q, Xu X, Zeng QL, Qi X, Zhang W. Wang J, et al. Among authors: feng y. Hepatol Int. 2022 Jun;16(3):691-701. doi: 10.1007/s12072-022-10332-9. Epub 2022 Apr 9. Hepatol Int. 2022. PMID: 35403977 Free PMC article.
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study.
Wang J, Zhang Q, Ai J, Liu D, Liu C, Xiang H, Gu Y, Guo Y, Lv J, Huang Y, Liu Y, Xu D, Chen S, Li J, Li Q, Liang J, Bian L, Zhang Z, Guo X, Feng Y, Liu L, Zhang X, Zhang Y, Xie F, Jiang S, Qin W, Wang X, Rao W, Zhang Q, Tian Q, Zhu Y, Cong Q, Xu J, Hou Z, Zhang N, Zhang A, Zu H, Wang Y, Yan Z, Du X, Hou A, Yan Y, Qiu Y, Wu H, Hu S, Deng Y, Ji J, Yang J, Huang J, Zhao Z, Zou S, Ji H, Ge G, Zhong L, He S, Yan X, Yangzhen BB, Qu C, Zhang L, Yang S, Gao X, Lv M, Zhu Q, Xu X, Zeng QL, Qi X, Zhang W. Wang J, et al. Among authors: feng y. Hepatol Int. 2024 Jun;18(3):1062-1063. doi: 10.1007/s12072-023-10598-7. Epub 2023 Oct 12. Hepatol Int. 2024. PMID: 37823938 No abstract available.
26,767 results
You have reached the last available page of results. Please see the User Guide for more information.